↓ Skip to main content

Cochrane Database of Systematic Reviews

Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients

Overview of attention for article published in Cochrane database of systematic reviews, September 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

twitter
2 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
104 Mendeley
Title
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
Published in
Cochrane database of systematic reviews, September 2014
DOI 10.1002/14651858.cd000239.pub2
Pubmed ID
Authors

Helle Krogh Johansen, Peter C Gøtzsche

Abstract

Systemic fungal infection is considered to be an important cause of morbidity and mortality in cancer patients, particularly those with neutropenia. Antifungal drugs are often given prophylactically, or empirically to patients with persistent fever.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Brazil 1 <1%
Unknown 101 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 14%
Other 10 10%
Student > Master 10 10%
Student > Ph. D. Student 8 8%
Researcher 7 7%
Other 21 20%
Unknown 33 32%
Readers by discipline Count As %
Medicine and Dentistry 40 38%
Nursing and Health Professions 8 8%
Biochemistry, Genetics and Molecular Biology 7 7%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Sports and Recreations 2 2%
Other 6 6%
Unknown 35 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2021.
All research outputs
#7,236,093
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,304
of 11,499 outputs
Outputs of similar age
#66,958
of 249,480 outputs
Outputs of similar age from Cochrane database of systematic reviews
#168
of 228 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,480 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.